| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Medicine, Division of Endocrinology, University of Arkansas for Medical Sciences, and The Central Arkansas Veterans Health Care System (P.A.K.), Little Rock, Arkansas 72205; and the Department of Medicine, Cedars-Sinai Medical Center, University of California School of Medicine (R.B.S., M.F.), Los Angeles, California 90048
Address all correspondence and requests for reprints to: Philip A. Kern, M.D., ACOS-Research, 151/LR, Central Arkansas Veterans Healthcare System, 4300 West 7th Street, Little Rock, Arkansas 72205. E-mail: kernphilipa{at}exchange.uams.edu
To examine the effects of weight loss on muscle oxidative properties, nine obese subjects (body mass index, 34 ± 1.5) had muscle biopsies before and after weight loss and weight stabilization. Weight loss ranged from 1332 kg and represented 20.8 ± 2.1% of initial weight. After weight loss, there was no change in the proportions of oxidative (type I and type IIa) fibers and also no change in mean fiber cross-sectional area, whereas there was a small, but significant, decrease in the relative interstitial space (P < 0.05). However, weight loss resulted in a 32 ± 6% (mean ± SEM) increase in capillary/fiber ratio and a 54% increase in capillary density (P < 0.05). In addition, there was a 41 ± 13% increase in succinate dehydrogenase (SDH) activity (P < 0.05). This increase in muscle capillarization and SDH activity was seen in all fiber types, even the relatively lower oxidative type IIx fibers. There was a strong correlation between the change in capillary/fiber ratio and the change in SDH activity (r = 0.82; P < 0.02). Thus, weight loss resulted in no change in muscle fiber type or cross-sectional area, but produced increases in capillary/fiber ratio, capillary density, and SDH activity, suggesting an increase in muscle oxidative capacity.
This article has been cited by other articles:
![]() |
F. G.S. Toledo, E. V. Menshikova, K. Azuma, Z. Radikova, C. A. Kelley, V. B. Ritov, and D. E. Kelley Mitochondrial Capacity in Skeletal Muscle Is Not Stimulated by Weight Loss Despite Increases in Insulin Action and Decreases in Intramyocellular Lipid Content Diabetes, April 1, 2008; 57(4): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi Skeletal muscle adaptations to testosterone and resistance training in men with COPD J Appl Physiol, October 1, 2007; 103(4): 1299 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yao-Borengasser, V. Varma, A. M. Bodles, N. Rasouli, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, A. A. Rashidi, et al. Retinol Binding Protein 4 Expression in Humans: Relationship to Insulin Resistance, Inflammation, and Response to Pioglitazone J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2590 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Varma, A. Yao-Borengasser, N. Rasouli, A. M. Bodles, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, R. E. McGehee Jr., et al. Human Visfatin Expression: Relationship to Insulin Sensitivity, Intramyocellular Lipids, and Inflammation J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 666 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yao-Borengasser, N. Rasouli, V. Varma, L. M. Miles, B. Phanavanh, T. N. Starks, J. Phan, H. J. Spencer III, R. E. McGehee Jr., K. Reue, et al. Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator-Activated Receptor {gamma} Activation. Diabetes, October 1, 2006; 55(10): 2811 - 2818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lopez-Soriano, C. Chiellini, M. Maffei, P. A. Grimaldi, and J. M. Argiles Roles of Skeletal Muscle and Peroxisome Proliferator-Activated Receptors in the Development and Treatment of Obesity Endocr. Rev., May 1, 2006; 27(3): 318 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rasouli, U. Raue, L. M. Miles, T. Lu, G. B. Di Gregorio, S. C. Elbein, and P. A. Kern Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E930 - E934. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Menshikova, V. B. Ritov, F. G. S. Toledo, R. E. Ferrell, B. H. Goodpaster, and D. E. Kelley Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E818 - E825. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perdomo, S. R. Commerford, A.-M. T. Richard, S. H. Adams, B. E. Corkey, R. M. O'Doherty, and N. F. Brown Increased {beta}-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation J. Biol. Chem., June 25, 2004; 279(26): 27177 - 27186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosenbaum, K. Vandenborne, R. Goldsmith, J.-A. Simoneau, S. Heymsfield, D. R. Joanisse, J. Hirsch, E. Murphy, D. Matthews, K. R. Segal, et al. Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R183 - R192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |